PRP-PBMC autologous cellular therapy (H-CYTE)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamePRP-PBMC autologous cellular therapy (H-CYTE)
Drug Alias Nameplatelet-rich plasma-platelet concentratePRP-PC therapy (H-CYTE)PRP-PCPRP-PBMC
ClassificationBiologics > Blood componentsCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesInnoveren Scientific Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnoveren Scientific Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A